Once-daily glycopyrronium bromide, a long-acting muscarinic antagonist, for chronic obstructive pulmonary disease: a systematic review of clinical benefit.
about
Tiotropium Bromide in Chronic Obstructive Pulmonary Disease and Bronchial AsthmaPositioning new pharmacotherapies for COPDLong-acting muscarinic receptor antagonists for the treatment of chronic airway diseasesClinical potential of aclidinium bromide in chronic obstructive pulmonary diseaseChronic obstructive pulmonary diseaseDiagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines.Role of combined indacaterol and glycopyrronium bromide (QVA149) for the treatment of COPD in Japan.Inhaled glycopyrronium bromide: a review of its use in patients with moderate to severe chronic obstructive pulmonary disease.Comparative efficacy of long-acting muscarinic antagonists in preventing COPD exacerbations: a network meta-analysis and meta-regression.Clinicopharmacological profile of the fixed-dose combination of aclidinium bromide and formoterol fumarate in the management of chronic obstructive pulmonary disease.Efficacy and Safety of Twice-Daily Glycopyrrolate Versus Placebo in Patients With COPD: The GEM2 Study.Emerging Therapeutic Options for the Management of COPD.Rapid simultaneous determination of indacaterol maleate and glycopyrronium bromide in inhaler capsules using a validated stability-indicating monolithic LC method.Role of nebulized glycopyrrolate in the treatment of chronic obstructive pulmonary disease.Novel long-acting antagonists of muscarinic ACh receptors.
P2860
Q26780553-53F20990-B7E8-4DFB-A573-7EF00FF46A44Q26798659-96D3473D-E44A-4B19-A04D-67CF4F7B669BQ27022636-122DBB94-9894-4448-915E-32C2617DB51AQ27023223-B45987C8-5FD9-4D2B-BA56-F4C0897511BDQ27027955-63187A02-D360-4F0D-9F2E-5BEAF89EA54BQ35538249-A586EE29-7CB5-4E93-BCB1-8FCB43C90EB1Q35541687-98448FEA-3F64-4A20-A753-36D1652E8557Q38107178-19B0FC0A-5FA5-4A92-B8BD-47EF7404A37CQ38317463-4A203C03-F5F4-46A0-B269-9C94314A5D47Q38371305-2107E755-0EDC-4DA7-B803-6D6BF5AC018EQ38604641-6F0F1622-60D9-43E2-A898-0451DDBBA0D8Q39936577-6AC96BCB-84CE-47DA-80F3-FDA3CDB3926AQ43059677-C675B46B-D857-465B-A75E-B5916AEAD0E2Q47102804-8CF27ED4-975E-4AF8-A1FC-0606ABC64CD1Q52677740-481891C7-2298-4E04-8C44-43B7E31FDB28
P2860
Once-daily glycopyrronium bromide, a long-acting muscarinic antagonist, for chronic obstructive pulmonary disease: a systematic review of clinical benefit.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Once-daily glycopyrronium brom ...... ic review of clinical benefit.
@en
type
label
Once-daily glycopyrronium brom ...... ic review of clinical benefit.
@en
prefLabel
Once-daily glycopyrronium brom ...... ic review of clinical benefit.
@en
P2860
P31
P921
P356
P1476
Once-daily glycopyrronium brom ...... ic review of clinical benefit.
@en
P2093
Charlotte Suppli Ulrik
P2860
P304
P356
10.2147/COPD.S35990
P407
P577
2012-09-26T00:00:00Z